Cargando…

Mouse models of epithelial ovarian cancer for preclinical studies

Epithelial ovarian cancer (EOC) is the leading cause of gynecological cancer-related mortality in the developed world. EOC is a heterogeneous disease represented by several histological and molecular subtypes. Therefore, exploration of relevant preclinical animal models that consider the heterogenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karakashev, Sergey, Zhang, Ru-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995272/ https://www.ncbi.nlm.nih.gov/pubmed/33527800 http://dx.doi.org/10.24272/j.issn.2095-8137.2020.382

Ejemplares similares

Harnessing preclinical models for the interrogation of ovarian cancer
por: Qin, Tianyu, et al.
Publicado: (2022)

Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
por: Martinez, Alejandra, et al.
Publicado: (2020)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application
por: Ciucci, Alessandra, et al.
Publicado: (2022)

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
por: Dumont, Sander, et al.
Publicado: (2019)

Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer
por: Greco, Adelaide, et al.
Publicado: (2017)

Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2013)

Preclinical humanized mouse model with ectopic ovarian tissues
por: FU, SHILONG, et al.
Publicado: (2014)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

Mouse models of breast cancer in preclinical research
por: Park, Mi Kyung, et al.
Publicado: (2018)

Progress toward overcoming hypoxia-induced resistance to solid tumor therapy
por: Karakashev, Sergey V, et al.
Publicado: (2015)

Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer
por: Chen, Jiayu, et al.
Publicado: (2021)

High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease
por: Heredia-Soto, Victoria, et al.
Publicado: (2018)

APP mouse models for Alzheimer's disease preclinical studies
por: Sasaguri, Hiroki, et al.
Publicado: (2017)

Development of a syngeneic mouse model of epithelial ovarian cancer
por: Quinn, Bridget A, et al.
Publicado: (2010)

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer
por: Capellero, S., et al.
Publicado: (2020)

Hypoxia/HIF1α induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2
por: Karakashev, Sergey V., et al.
Publicado: (2015)

Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human
por: Chiang, Cheryl Lai-Lai, et al.
Publicado: (2021)

Mouse models of colorectal cancer as preclinical models
por: McIntyre, Rebecca E., et al.
Publicado: (2015)

Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2020)

Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models
por: Fiordelisi, M. F., et al.
Publicado: (2019)

A Syngeneic Mouse Model of Epithelial Ovarian Cancer Port Site Metastases
por: Wilkinson-Ryan, Ivy, et al.
Publicado: (2018)

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches
por: Zakarya, Razia, et al.
Publicado: (2020)

Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies
por: Odunsi, Adekunle, et al.
Publicado: (2020)

Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis
por: Kitz, Jenna, et al.
Publicado: (2018)

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
por: Maenhoudt, Nina, et al.
Publicado: (2020)

Checkpoint inhibitors in ovarian cancer: A review of preclinical data
por: Doo, David W., et al.
Publicado: (2019)

Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors In Vitro and in Preclinical Mouse Model
por: Loganathan, Sivakumar, et al.
Publicado: (2012)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Tumor metabolism rewiring in epithelial ovarian cancer
por: Wang, Ming, et al.
Publicado: (2023)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Estrogen, Progesterone and Epithelial Ovarian Cancer
por: Ho, Shuk-Mei
Publicado: (2003)

Chemokine Receptors in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2013)

Targeted Therapies in Epithelial Ovarian Cancer
por: Dean, Emma, et al.
Publicado: (2010)

Immunotherapy Advances for Epithelial Ovarian Cancer
por: Hartnett, Erin G., et al.
Publicado: (2020)

The BRCA Gene in Epithelial Ovarian Cancer
por: Sánchez-Lorenzo, Luisa, et al.
Publicado: (2022)

Preclinical Models of Adrenocortical Cancer
por: Sedlack, Andrew J. H., et al.
Publicado: (2023)

Ovarian cancer mouse models: a summary of current models and their limitations
por: Fong, Miranda Y, et al.
Publicado: (2009)

Genetically Engineered Mouse Models for Drug Development and Preclinical Trials
por: Lee, Ho
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_atebfoeqeokfv9rhrn761l4v8i